NCT04869319

Brief Summary

Studying subjects with HbA1C tests \>10 and no follow-up test within 6 months and appointments scheduled in the next 60 days from data run date. Subjects who receive intervention message may be more likely to follow up with their provider to schedule a follow up HbA1C test.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,403

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 13, 2020

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

March 18, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 3, 2021

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 28, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 28, 2024

Completed
Last Updated

April 10, 2024

Status Verified

April 1, 2024

Enrollment Period

3.7 years

First QC Date

March 18, 2021

Last Update Submit

April 9, 2024

Conditions

HemoglobinsDiagnostic Tests

Outcome Measures

Primary Outcomes (1)

  • Rate of follow up A1C within 9 months after original A1C (allowing 3 months after email is sent)

    This outcome measures the rate at which participants complete an A1C test within 3 months of the message intervention being sent and 9 months of their original test.

    2 years

Study Arms (2)

MyChart message

MyChart message subjects with high A1C blood tests to help manage their diabetes and prevent some of the complications caused by high sugars. The message recommends that they schedule a visit with their doctor who can recheck the blood test and help get their diabetes under control.

Behavioral: MyChart message

No MyChart message

No message

Interventions

MyChart messageBEHAVIORAL

Message subjects through MyChart to follow-up with their provider to schedule a follow up HbA1C test.

MyChart message

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

MyChart active patients with HbA1C tests \>10 and no follow-up test within 6 months and no appointments scheduled in the next 60 days from data run date

You may qualify if:

  • MyChart active patients with HbA1C tests \>10 and no follow-up test within 6 months and no appointments scheduled in the next 60 days from data run date

You may not qualify if:

  • Patients with a scheduled appointment within 60 days from time algorithm is run; hospital encounters; non English or Spanish patients as indicated by primary language in Epic

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NYU Langone Health

New York, New York, 10016, United States

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 18, 2021

First Posted

May 3, 2021

Study Start

July 13, 2020

Primary Completion

March 28, 2024

Study Completion

March 28, 2024

Last Updated

April 10, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations

US(1)